7 powodów, dla których warto stosować difenhydraminę w sporadycznej bezsenności Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
sty 15, 2024
Słowa kluczowe:
difenhydramina, leczenie bezsenności, łagodna przejściowa bezsenność
##plugins.themes.bootstrap3.article.main##
Abstrakt
Difenhydramina jest lekiem przeciwhistaminowym I generacji o działaniu sedatywnym. Z tego powodu rozważa się ją jako alternatywną opcję w farmakologicznym leczeniu przejściowych zaburzeń snu. Nie ma potencjału uzależniającego i w niektórych krajach (także w Polsce) jest dostępna bez recepty.
##plugins.themes.bootstrap3.article.details##
Jak cytować
Skalski, M. (2024). 7 powodów, dla których warto stosować difenhydraminę w sporadycznej bezsenności. Medycyna Faktów . Pobrano z https://www.journalsmededu.pl/index.php/jebm/article/view/2943
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Carruthers SG, Shoeman DW, Hignite CE et al. Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharm Ther. 1978; 23(4): 375-82.
2. Glazko AJ, Dill WA, Young RM et al. Metabolic disposition of diphenhydramine. Clin Pharmacol Ther. 1974; 16(6): 1066-76.
3. Simons FER, Simons KJ. Histamine and H1-antihistamines: Celebrating a century of progress. J Allergy Clin Immunol. 2011; 128(6): 1139-50.e4.
4. Rickels K, Morris RJ, Newman H et al. Diphenhydramine in insomniac family practice patients: a double-blind study. J Clin Pharmacol. 1983; 23(5-6): 234-42.
5. Skalski M. Zaburzenia snu w codziennej praktyce. 2nd ed. Medical Tribune, Warszawa 2018.
6. Yoder KE, Shaffer ML, La Tournous SJ et al. Child Assessment of Dextromethorphan, Diphenhydramine, and Placebo for Nocturnal Cough Due to Upper Respiratory Infection. Clin Pediatr. 2006; 45(7): 633-40.
7. Suni E, Rehman A. Sleep Guidelines During the COVID-19 Pandemic (access: 7.11.2023).
8. Morin CM, Koette U, Bastien C et al. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. Sleep. 2005; 28(11): 1465-71.
9. Gengo FM, Manning C. A review of the effects of antihistamines on mental processes related to automobile driving. J Allergy Clin Immunol. 1990; 86(6): 1034-9.
10. Ramaekers JG, O’Hanlon JF. Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. Eur J Clin Pharmacol. 1994; 47(3): 261-6.
11. Verster JC, de Veert AM, Bijtjes SI et al. Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial. Psychopharmacology. 2003; 169(1): 84-90.
12. Charakterystyka produktu leczniczego Senolek z 2023 r.
13. Apap Noc – ulotka – Rejestr produktów leczniczych (access: 3.06.2019).
14. Culpepper L, Wingertzahn MA. Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia: A Systematic Review of Efficacy and Safety. Prim. Care Companion. CNS Disord. 2015; 17(6): 10.4088/PCC.15r01798. http://doi.org/10.4088/PCC.15r01798.
15. Cooper S, Laurora I, Wang Y et al. Efficacy and tolerability studies evaluating a sleep aid and analgesic combination of naproxen sodium and diphenhydramine in the dental impaction pain model in subjects with induced transient insomnia. Int J Clin Pract. 2015; 69(10): 1149-58.
16. Indeks leków [online].
17. Paul IM, Yoder KE, Crowell KR et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics. 2004; 114(1): e85-90.
18. Lin RY, Curry A, Pesola GR et al. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med. 2000; 36(5): 462-8.
19. Friedman BW, Cabral L, Adevunmi V et al. Diphenhydramine as Adjuvant Therapy for Acute Migraine: An Emergency Department-Based Randomized Clinical Trial. Ann Emerg Med. 2016; 67(1): 32-9.e3.
20. Swidan SZ, Lake AE, Saper JR. Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache. Curr Pain Head Rep. 2005; 9(1): 65-70.
21. Thormann M, Amthauer H, Adolf D et al. Efficacy of diphenhydramine in the prevention of vertigo and nausea at 7 T MRI. Eur J Radiol. 2013; 82(5): 768-72.
22. Kudo Y, Kurihara M. Clinical evaluation of diphenhydramine hydrochloride for the treatment of insomnia in psychiatric patients: a double-blind study. J Clin Pharmacol. 1990; 30(11): 1041-8.
23. Cengiz M, Baysal Z, Ganidagli S. Oral sedation with midazolam and diphenhydramine compared with midazolam alone in children undergoing magnetic resonance imaging. Paediatr Anaesth. 2006; 16(6): 621-6.
24. Glass JR, Sproule BA, Herrmann N et al. Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial. J Clin Psychopharmacol. 2008; 28(2): 182-8.
25. Hryniewicz W, Albrecht P, Radzikowski A (ed). Narodowy Program Ochrony Antybiotyków. Rekomendacje postępowania w zakażeniach układu oddechowego. Narodowy Program Ochrony Antybiotyków. Warszawa 2016.
26. Merenstein D, Diener-West M, Halbower AC et al. The trial of infant response to diphenhydramine: the TIRED study – a randomized, controlled, patient-oriented trial. Arch Pediatr Adolesc Med. 2006; 160(7): 707-12.
27. Yangzom N, Gottschlich MM, Ossege J et al. The Effect of Diphenhydramine on Sleep in Pediatric Burn Patients: A Secondary Analysis. J Burn Care Res. 2015; 36(2): 266-71.
2. Glazko AJ, Dill WA, Young RM et al. Metabolic disposition of diphenhydramine. Clin Pharmacol Ther. 1974; 16(6): 1066-76.
3. Simons FER, Simons KJ. Histamine and H1-antihistamines: Celebrating a century of progress. J Allergy Clin Immunol. 2011; 128(6): 1139-50.e4.
4. Rickels K, Morris RJ, Newman H et al. Diphenhydramine in insomniac family practice patients: a double-blind study. J Clin Pharmacol. 1983; 23(5-6): 234-42.
5. Skalski M. Zaburzenia snu w codziennej praktyce. 2nd ed. Medical Tribune, Warszawa 2018.
6. Yoder KE, Shaffer ML, La Tournous SJ et al. Child Assessment of Dextromethorphan, Diphenhydramine, and Placebo for Nocturnal Cough Due to Upper Respiratory Infection. Clin Pediatr. 2006; 45(7): 633-40.
7. Suni E, Rehman A. Sleep Guidelines During the COVID-19 Pandemic (access: 7.11.2023).
8. Morin CM, Koette U, Bastien C et al. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. Sleep. 2005; 28(11): 1465-71.
9. Gengo FM, Manning C. A review of the effects of antihistamines on mental processes related to automobile driving. J Allergy Clin Immunol. 1990; 86(6): 1034-9.
10. Ramaekers JG, O’Hanlon JF. Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. Eur J Clin Pharmacol. 1994; 47(3): 261-6.
11. Verster JC, de Veert AM, Bijtjes SI et al. Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial. Psychopharmacology. 2003; 169(1): 84-90.
12. Charakterystyka produktu leczniczego Senolek z 2023 r.
13. Apap Noc – ulotka – Rejestr produktów leczniczych (access: 3.06.2019).
14. Culpepper L, Wingertzahn MA. Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia: A Systematic Review of Efficacy and Safety. Prim. Care Companion. CNS Disord. 2015; 17(6): 10.4088/PCC.15r01798. http://doi.org/10.4088/PCC.15r01798.
15. Cooper S, Laurora I, Wang Y et al. Efficacy and tolerability studies evaluating a sleep aid and analgesic combination of naproxen sodium and diphenhydramine in the dental impaction pain model in subjects with induced transient insomnia. Int J Clin Pract. 2015; 69(10): 1149-58.
16. Indeks leków [online].
17. Paul IM, Yoder KE, Crowell KR et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics. 2004; 114(1): e85-90.
18. Lin RY, Curry A, Pesola GR et al. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med. 2000; 36(5): 462-8.
19. Friedman BW, Cabral L, Adevunmi V et al. Diphenhydramine as Adjuvant Therapy for Acute Migraine: An Emergency Department-Based Randomized Clinical Trial. Ann Emerg Med. 2016; 67(1): 32-9.e3.
20. Swidan SZ, Lake AE, Saper JR. Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache. Curr Pain Head Rep. 2005; 9(1): 65-70.
21. Thormann M, Amthauer H, Adolf D et al. Efficacy of diphenhydramine in the prevention of vertigo and nausea at 7 T MRI. Eur J Radiol. 2013; 82(5): 768-72.
22. Kudo Y, Kurihara M. Clinical evaluation of diphenhydramine hydrochloride for the treatment of insomnia in psychiatric patients: a double-blind study. J Clin Pharmacol. 1990; 30(11): 1041-8.
23. Cengiz M, Baysal Z, Ganidagli S. Oral sedation with midazolam and diphenhydramine compared with midazolam alone in children undergoing magnetic resonance imaging. Paediatr Anaesth. 2006; 16(6): 621-6.
24. Glass JR, Sproule BA, Herrmann N et al. Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial. J Clin Psychopharmacol. 2008; 28(2): 182-8.
25. Hryniewicz W, Albrecht P, Radzikowski A (ed). Narodowy Program Ochrony Antybiotyków. Rekomendacje postępowania w zakażeniach układu oddechowego. Narodowy Program Ochrony Antybiotyków. Warszawa 2016.
26. Merenstein D, Diener-West M, Halbower AC et al. The trial of infant response to diphenhydramine: the TIRED study – a randomized, controlled, patient-oriented trial. Arch Pediatr Adolesc Med. 2006; 160(7): 707-12.
27. Yangzom N, Gottschlich MM, Ossege J et al. The Effect of Diphenhydramine on Sleep in Pediatric Burn Patients: A Secondary Analysis. J Burn Care Res. 2015; 36(2): 266-71.